| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 07/05/2001 | WO2001047892A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | WO2001047877A2 Process for the preparation of pure citalopram |
| 07/05/2001 | WO2001047859A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | WO2001047564A2 Labelled ascorbic acid derivatives |
| 07/05/2001 | WO2001012592A3 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 07/05/2001 | WO2001009065A3 Nitration in a static micromixer |
| 07/05/2001 | WO2000050376A3 Efficient synthesis of alkyl carbonates |
| 07/05/2001 | US20010007034 Tetrahydrofuran-adducted Group II beta-diketonate complexes as source reagents for chemical vapor deposition |
| 07/05/2001 | US20010006975 Raf kinase inhibitors |
| 07/05/2001 | US20010006944 Treating noninvasive fungus-induced rhinosinusitis by mucoadministering an antifungal agent; culturing noninvasive fungus from a mammalian mucus sample for antigen/antibody production; apparatus for collecting nasal mucus |
| 07/05/2001 | US20010006619 Compounds for cancer imaging and therapy |
| 07/05/2001 | DE19963869A1 Verfahren zur Kühlung eines heißen Reaktionsgases Method for cooling a hot reaction gas |
| 07/05/2001 | DE19961604A1 Verfahren zur Herstellung von 1,3-disubstituierten 2-Nitroguanidinen A process for the preparation of 1,3-disubstituted 2-nitroguanidines |
| 07/05/2001 | CA2396579A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | CA2395404A1 Method for the preparation of citalopram |
| 07/05/2001 | CA2394959A1 Labelled ascorbic acid derivatives |
| 07/05/2001 | CA2393583A1 Compounds active at the glucocorticoid receptor |
| 07/04/2001 | EP1113332A1 Photographic element, compound, and process |
| 07/04/2001 | EP1113105A2 Human sweat malodor counteractant composition and process for using same |
| 07/04/2001 | EP1112776A1 Pd-Re catalyst for hydrogenating dicarboxylic acids |
| 07/04/2001 | EP1112269A2 Hiv protease inhibitors |
| 07/04/2001 | EP1112261A1 2-ethyl-2,3-dihydrobenzofuran-carboxylic acid ester derivative, preparation method and use for preparing efaroxan derivatives |
| 07/04/2001 | EP1112252A1 Kappa agonist compounds and pharmaceutical formulations thereof |
| 07/04/2001 | EP1112240A1 The addition of oxygen nucleophiles to vinyl epoxides |
| 07/04/2001 | EP0925284B1 New polycyclic phthalazin derivatives and their use |
| 07/04/2001 | EP0825980B1 Cyclopentane heptan(ene)oic acid, 2-heteroarylakenyl derivatives as therapeutic agents for the treatment of ocular hypertension |
| 07/04/2001 | EP0634927B1 Treatment and prophylaxis of diseases caused by parasites, or bacteria |
| 07/04/2001 | CN1302294A Method for producing phthalic anhydride by means of catalytic vapor-phase oxidation of o-xylol/naphthalene mixtures |
| 07/04/2001 | CN1302287A Bioreductive cytotoxic agents |
| 07/04/2001 | CN1067991C Aminoalkyl substituted benzo-heterocyclic compounds |
| 07/03/2001 | US6255528 Reacting an alkylfluorobromobenzene or fluorobromobenzene with acrylamide in presence of palladium catalyst, hydrogenating the resulting arylacrylamide, and then rearranging it |
| 07/03/2001 | US6255498 Method for synthesizing diaryl-substituted heterocyclic compounds, including tetrahydrofurans |
| 07/03/2001 | US6255349 Alph-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group |
| 07/03/2001 | US6255342 Pesticides |
| 07/03/2001 | US6255339 Tetrahydronaphthofuranone derivatives and process for producing the same |
| 07/03/2001 | US6255338 Use of calcium intracellular store inactivators and formulations thereof as cell growth inhibitors |
| 07/03/2001 | US6255304 Aids therapy |
| 06/28/2001 | WO2001046175A1 Diamidine compounds as dna minor groove binders |
| 06/28/2001 | WO2001046174A1 Novel compounds |
| 06/28/2001 | WO2001046171A1 Amidine derivatives which are inhibitors of nitric oxide synthase |
| 06/28/2001 | WO2001046170A1 Amidine derivatives which are inhibitors of nitric oxide synthase |
| 06/28/2001 | WO2001046169A1 Process for producing carbonyl compounds by dehydrogenation of alcohols |
| 06/28/2001 | WO2001046167A1 α-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS |
| 06/28/2001 | WO2001046160A1 Method for production of 1,3-disubstituted 2-nitroguanidines |
| 06/28/2001 | WO2001046125A2 Cd45 inhibitors |
| 06/28/2001 | WO2001046110A2 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 06/28/2001 | WO2001045694A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045483A2 Method for the preparation of pure citalopram |
| 06/28/2001 | WO2001010834A3 Antibacterial agents |
| 06/28/2001 | WO2001009122A3 Serotonergic benzofurans |
| 06/28/2001 | WO2000066104A3 Ace-2 inhibiting compounds and methods of use thereof |
| 06/28/2001 | US20010005753 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands |
| 06/28/2001 | DE19961897A1 Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen Using a film coating as taste coating of pharmaceutical dosage forms |
| 06/28/2001 | CA2395300A1 Novel compounds |
| 06/28/2001 | CA2395191A1 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 06/28/2001 | CA2394603A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | CA2392150A1 Diamidine compounds as dna minor groove binders |
| 06/27/2001 | EP1110958A1 Alpha-arylethylpiperazine derivatives as neurokinin antagonists |
| 06/27/2001 | EP1110603A1 Process for the synthesis of VPO catalysts |
| 06/27/2001 | EP1110548A1 Substances having antiobese and visceral fat-reducing functions and utilization thereof |
| 06/27/2001 | EP1110544A2 Use of a film coating as taste masking coating for oral dosage forms |
| 06/27/2001 | EP1109805A1 Inhibitors of bacterial nad synthetase |
| 06/27/2001 | EP1109799A1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors |
| 06/27/2001 | EP0929541B1 Process for preparing phthalides |
| 06/27/2001 | EP0824518B1 (het)aryloxy-, -thio-, aminocrotonates, methods of preparing them and their use as insecticides and fungicides |
| 06/27/2001 | EP0797564B1 Lignans, a process for their production and pharmaceutical compositions and uses thereof |
| 06/27/2001 | EP0718281B1 Cyclohexanediurea derivative and process for producing the same |
| 06/27/2001 | CN1301261A Production of furanones |
| 06/27/2001 | CN1300590A Use of coating as taste masking agent for oral preparation |
| 06/27/2001 | CN1067678C Alkyl heterocyclic compound and preparation method thereof, and medicinal composition containing that kind of compound |
| 06/26/2001 | US6252083 Fungicides, insecticides, nematocides |
| 06/26/2001 | US6252072 Hydrolysis of the corresponding triazine compound |
| 06/26/2001 | US6251940 Administering to the mammal suffering from a diseases responsive to inhibit monocyte and/or macrophase and/or lymphocyte activation and of lymphocyte proliferation an amide derivative |
| 06/26/2001 | US6251936 Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia |
| 06/26/2001 | US6251925 An agonists for human beta-3 adrenoceptor |
| 06/26/2001 | US6251899 Microbioicides |
| 06/26/2001 | US6251830 Pesticides and herbicides |
| 06/26/2001 | US6251827 Acylsulfamoylbenzamides, crop protection compositions comprising them, and processes for their preparation |
| 06/26/2001 | US6251642 Enzymatically converting amylopectin to alpha-(1,4)-linked oligosaccharide, oxidizing basic anion exchange resin to (s)-3,4-dihydroxybutyric acid, esterifying with alcohol and acid catalyst, then cyclizing with acid catalyst |
| 06/22/2001 | CA2329565A1 Process for the synthesis of vpo catalysts |
| 06/21/2001 | WO2001044324A2 Polymerization of olefins |
| 06/21/2001 | WO2001044226A1 Serine protease inhibitors |
| 06/21/2001 | WO2001044222A1 Process for the preparation of trans-3-alkyloxy-4-hydroxytetrahydrofuran |
| 06/21/2001 | WO2001044221A1 Hydroxamic acid derivatives as inhibitors of human cd23 and of the tnf release |
| 06/21/2001 | WO2001044172A1 Salicylamides as serine protease and factor xa inhibitors |
| 06/21/2001 | WO2001044148A1 Process for the co-production of aliphatic diols and cyclic ethers |
| 06/21/2001 | WO2001043525A2 Method for the preparation of citalopram |
| 06/21/2001 | US20010004629 Improved toleration by crops, insecticidal and/or spectrum of action |
| 06/21/2001 | DE10061948A1 Lichtempfindliche Harzzusammensetzung A photosensitive resin composition |
| 06/21/2001 | CA2401236A1 Method for the preparation of citalopram |
| 06/21/2001 | CA2394639A1 Salicylamides as serine protease and factor xa inhibitors |
| 06/20/2001 | EP1108706A1 Catalytic synthesis of aldehydes by direct hydrogenation of carboxylic acids |
| 06/20/2001 | EP1108702A1 Process for the co-production of aliphatic diols and cyclic ethers |
| 06/20/2001 | EP1107961A1 Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin and its analogs |
| 06/20/2001 | EP0890176B1 Proton conductor in liquid form |
| 06/20/2001 | EP0858454B1 Combinatorial solid phase synthesis of a library of benzofuran derivatives |
| 06/20/2001 | EP0757682B1 Benzofuran derivatives useful as inhibitors of bone resorption |
| 06/20/2001 | EP0740690B1 Monoazo dyes containing a fluorosulphonyl group and use thereof |
| 06/20/2001 | EP0639566B1 Cyclic compound |
| 06/20/2001 | CN1300278A Benzamide derivatives for the treatment of diseases mediated by cytokines |